GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » C4X Discovery Holdings PLC (FRA:C4J) » Definitions » Net Current Asset Value

C4X Discovery Holdings (FRA:C4J) Net Current Asset Value : €0.11 (As of Jan. 2024)


View and export this data going back to 2020. Start your Free Trial

What is C4X Discovery Holdings Net Current Asset Value?

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

C4X Discovery Holdings's net current asset value per share for the quarter that ended in Jan. 2024 was €0.11.

The historical rank and industry rank for C4X Discovery Holdings's Net Current Asset Value or its related term are showing as below:

FRA:C4J' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 1.05   Med: 5.11   Max: 16.37
Current: 1.05

During the past 12 years, the highest Price-to-Net-Current-Asset-Value Ratio of C4X Discovery Holdings was 16.37. The lowest was 1.05. And the median was 5.11.

FRA:C4J's Price-to-Net-Current-Asset-Value is ranked better than
86.56% of 1027 companies
in the Biotechnology industry
Industry Median: 3.94 vs FRA:C4J: 1.05

C4X Discovery Holdings Net Current Asset Value Historical Data

The historical data trend for C4X Discovery Holdings's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C4X Discovery Holdings Net Current Asset Value Chart

C4X Discovery Holdings Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Net Current Asset Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.10 0.06 0.09 0.05 0.02

C4X Discovery Holdings Semi-Annual Data
Jul14 Jan15 Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.05 0.05 0.02 0.11

Competitive Comparison of C4X Discovery Holdings's Net Current Asset Value

For the Biotechnology subindustry, C4X Discovery Holdings's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


C4X Discovery Holdings's Price-to-Net-Current-Asset-Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, C4X Discovery Holdings's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where C4X Discovery Holdings's Price-to-Net-Current-Asset-Value falls into.



C4X Discovery Holdings Net Current Asset Value Calculation

C4X Discovery Holdings's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Jul. 2023 is calculated as

Net Current Asset Value Per Share(A: Jul. 2023 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(8.268-2.623-0-0)/252.12
=0.02

C4X Discovery Holdings's Net Current Asset Value (NCAV) per share for the quarter that ended in Jan. 2024 is calculated as

Net Current Asset Value Per Share(Q: Jan. 2024 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(28.818-1.888-0-0)/252.227
=0.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


C4X Discovery Holdings  (FRA:C4J) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


C4X Discovery Holdings Net Current Asset Value Related Terms

Thank you for viewing the detailed overview of C4X Discovery Holdings's Net Current Asset Value provided by GuruFocus.com. Please click on the following links to see related term pages.


C4X Discovery Holdings (FRA:C4J) Business Description

Traded in Other Exchanges
Address
53 Portland Street, Manchester One, Manchester, GBR, M1 3LD
C4X Discovery Holdings PLC is a drug discovery and development company. It has various proprietary and synergistic software platforms Taxonomy3, Conformetrix, and 4Sight. Taxonomy3 is a novel in silico platform technology that utilizes proprietary ground-breaking mathematical algorithms to perform complex multivariate analysis of genetic data. Conformetrix enables rational, accelerated 4D structural drug design using experimental data rather than theoretical data. The 4Sight allows its research scientists to view, understand and interrogate the complex, multidimensional molecular shape data of drug molecules.

C4X Discovery Holdings (FRA:C4J) Headlines

No Headlines